HEC Infra Projects Submits Q4/FY26 Financial Results to NSE
HEC Infra Projects Limited has filed its financial results for the period ended March 31, 2026 following a board meeting, as disclosed on NSE.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
3,484 articles published
Results for “INA” · in Corporate announcement — Clear filters
HEC Infra Projects Limited has filed its financial results for the period ended March 31, 2026 following a board meeting, as disclosed on NSE.
Read articleGautam Exim Limited has concluded its adjourned board meeting on May 28, 2026, disclosing audited standalone financial results for the half year and year ended March 31, 2026, as per SEBI LODR regulations.
Read articleGautam Exim Limited's board of directors concluded an adjourned meeting on May 28, 2026, approving standalone financial results for the half year and fiscal year ending March 31, 2026, with statutory auditors issuing an unmodified opinion.
Read articleGautam Exim Limited's adjourned board meeting concluded on May 28, 2026, with the board approving audited standalone financial results for the half year and year ended March 31, 2026.
Read articleGautam Exim Limited's board meeting on May 28, 2026 concluded with approval of standalone audited financial results for the half year and year ended March 31, 2026, accompanied by an unmodified audit opinion.
Read articleLincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for FY2026, subject to approval at the upcoming Annual General Meeting.
Read articleLincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for FY26, representing an 18% return on the Rs 10 face value.
Read articleNahar Capital and Financial Services recommends Rs 1.50 final dividend per equity share for FY26. Board meeting held May 28, 2026.
Read articleLincoln Pharmaceuticals has proposed a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026, awaiting shareholder approval at the ensuing AGM.
Read articleLincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026.
Read articleNahar Spinning Mills Limited has disclosed its financial results for the period ended March 31, 2026, following a board meeting outcome submitted to the NSE.
Read articleNahar Spinning Mills Limited (NAHARSPING) has submitted its financial results for the period ended March 31, 2026 to the NSE following a board meeting.
Read articleNahar Spinning Mills has filed Q4 and FY2026 financial results with NSE following a board meeting. Investors are monitoring for further disclosures.
Read articleQuick Notification
Smart analysis of market trends
Notifications on crucial events
Alerts in the chat you already use
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."
— Aditya M., Active Trader